256 related articles for article (PubMed ID: 31532792)
1. Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers.
Cunningham PN; Wang Z; Grove ML; Cooper-DeHoff RM; Beitelshees AL; Gong Y; Gums JG; Johnson JA; Turner ST; Boerwinkle E; Chapman AB
PLoS One; 2019; 14(9):e0221957. PubMed ID: 31532792
[TBL] [Abstract][Full Text] [Related]
2. Influence of autoantibodies against AT1 receptor and AGTR1 polymorphisms on candesartan-based antihypertensive regimen: results from the study of optimal treatment in hypertensive patients with anti-AT1-receptor autoantibodies trial.
Sun Y; Liao Y; Yuan Y; Feng L; Ma S; Wei F; Wang M; Zhu F
J Am Soc Hypertens; 2014 Jan; 8(1):21-7. PubMed ID: 24131669
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.
Nadkarni GN; Galarneau G; Ellis SB; Nadukuru R; Zhang J; Scott SA; Schurmann C; Li R; Rasmussen-Torvik LJ; Kho AN; Hayes MG; Pacheco JA; Manolio TA; Chisholm RL; Roden DM; Denny JC; Kenny EE; Bottinger EP
J Am Coll Cardiol; 2017 Mar; 69(12):1564-1574. PubMed ID: 28335839
[TBL] [Abstract][Full Text] [Related]
4. Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker.
Turner ST; Bailey KR; Schwartz GL; Chapman AB; Chai HS; Boerwinkle E
Hypertension; 2012 Jun; 59(6):1204-11. PubMed ID: 22566498
[TBL] [Abstract][Full Text] [Related]
5. Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis.
Knudsen ST; Andersen NH; Poulsen SH; Eiskjaer H; Hansen KW; Helleberg K; Poulsen PL; Mogensen CE
Am J Hypertens; 2008 Feb; 21(2):172-6. PubMed ID: 18188164
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in African-American patients with hypertension.
Papademetriou V; Narayan P; Kokkinos P
J Clin Hypertens (Greenwich); 2004 Jun; 6(6):310-4. PubMed ID: 15187493
[TBL] [Abstract][Full Text] [Related]
7. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
[TBL] [Abstract][Full Text] [Related]
8.
Chen TK; Tin A; Peralta CA; Appel LJ; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
Clin J Am Soc Nephrol; 2017 Nov; 12(11):1771-1777. PubMed ID: 29051146
[TBL] [Abstract][Full Text] [Related]
9. Addition of manidipine improves the antiproteinuric effect of candesartan in hypertensive patients with type II diabetes and microalbuminuria.
Fogari R; Corradi L; Zoppi A; Lazzari P; Mugellini A; Preti P; Rinaldi A
Am J Hypertens; 2007 Oct; 20(10):1092-6. PubMed ID: 17903693
[TBL] [Abstract][Full Text] [Related]
10. Effects of protein coding polymorphisms in the kallikrein 1 gene on baseline blood pressure and antihypertensive response to irbesartan in Chinese hypertensive patients.
Jiang S; Hsu YH; Venners SA; Zhang Y; Xing H; Wang X; Xu X
J Hum Hypertens; 2011 May; 25(5):327-33. PubMed ID: 20613781
[TBL] [Abstract][Full Text] [Related]
11. Genome Wide Analysis Approach Suggests Chromosome 2 Locus to be Associated with Thiazide and Thiazide Like-Diuretics Blood Pressure Response.
Singh S; McDonough CW; Gong Y; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Turner ST; Cooper-DeHoff RM; Johnson JA
Sci Rep; 2019 Nov; 9(1):17323. PubMed ID: 31754133
[TBL] [Abstract][Full Text] [Related]
12. Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension.
Lee HY; Hong BK; Chung WJ; Lee BK; Lee SH; Jeon DW; Ahn YK; Kim D; Park CK; Kim SH; Jung HO; Kim BO; Choi D
Clin Ther; 2011 Aug; 33(8):1043-56. PubMed ID: 21831438
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 1 receptor blockade to control blood pressure in postmenopausal women: influence of hormone replacement therapy.
Fernández-Vega F; Abellán J; Vegazo O; De Vinuesa SG; Rodríguez JC; Maceira B; de Castro SS; Nicolás RR; Luño J
Kidney Int Suppl; 2002 Dec; (82):S36-41. PubMed ID: 12410853
[TBL] [Abstract][Full Text] [Related]
14.
Chung CP; Karakoc G; Dickson A; Liu G; Gamboa JL; Mosley JD; Cox NJ; Kawai VK
Lupus; 2023 May; 32(6):763-770. PubMed ID: 37105192
[TBL] [Abstract][Full Text] [Related]
15. Predictors of blood pressure response to the angiotensin receptor blocker candesartan in essential hypertension.
Canzanello VJ; Baranco-Pryor E; Rahbari-Oskoui F; Schwartz GL; Boerwinkle E; Turner ST; Chapman AB
Am J Hypertens; 2008 Jan; 21(1):61-6. PubMed ID: 18091745
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial comparing the velocities of the antihypertensive effects on home blood pressure of candesartan and candesartan with hydrochlorothiazide.
Hosaka M; Metoki H; Satoh M; Ohkubo T; Asayama K; Kikuya M; Inoue R; Obara T; Hirose T; Imai Y;
Hypertens Res; 2015 Oct; 38(10):701-7. PubMed ID: 26041602
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension.
Fogari R; Mugellini A; Derosa G;
J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):139-44. PubMed ID: 17907102
[TBL] [Abstract][Full Text] [Related]
18. Associations between APOL1 genetic variants and blood pressure in African American mothers and children from a U.S. pregnancy cohort: Modification by air pollution exposures.
Ni Y; Simpson CL; Davis RL; Szpiro AA; Karr CJ; Kovesdy CP; Hjorten RC; Tylavsky FA; Bush NR; LeWinn KZ; Winkler CA; Kopp JB; Obi Y
Environ Res; 2022 Sep; 212(Pt A):113186. PubMed ID: 35358541
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: a clinical experience trial. ACTION Study Investigators.
Weir MR; Weber MA; Neutel JM; Vendetti J; Michelson EL; Wang RY
Am J Hypertens; 2001 Jun; 14(6 Pt 1):567-72. PubMed ID: 11411737
[TBL] [Abstract][Full Text] [Related]
20. Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies.
Wei F; Jia XJ; Yu SQ; Gu Y; Wang L; Guo XM; Wang M; Zhu F; Cheng X; Wei YM; Zhou ZH; Fu M; Liao YH;
Heart; 2011 Mar; 97(6):479-84. PubMed ID: 21296780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
